Prozac “unsafe & ineffective” for young people, analysis finds
Reanalysis of regulatory data finds that attempted suicides were excluded from the final journal publication, and the journal has not corrected the record.
BY MARYANNE DEMASI, PHD | MAY 9, 2023
A new analysis finds that Prozac (generic name fluoxetine) is unsafe and ineffective for treating depression in children and adolescents.
Regulatory documents show that trial participants attempted suicide after taking fluoxetine, but these events were excluded from the final journal publication.
I notified the journal of the new findings, but the editor refuses to correct the record.
Prozac approval
In 2002, Prozac (fluoxetine), manufactured by Eli Lilly, was FDA-approved for the treatment of depression in children and adolescents based on data from two clinical trials.
The two trials were published in peer-reviewed journals in 1997 (Study 1) and 2002 (Study 2).
Both publications reported a small benefit of fluoxetine over placebo in young people with depression and there appeared to be no major safety concerns.
Subsequently, fluoxetine became one of the most prescribed antidepressants for children aged 0-19 years in the US, and is in the top 5 most prescribed antidepressants in England.
Restoring old trials
An initiative called Restoring Invisible and Abandoned Trials (RIAT) has enabled researchers to “restore” old clinical trial publications by analysing documents submitted to drug regulators by the drug companies.
These analyses have revealed that serious drug harms are either underreported or excluded entirely from medical journals.
Physician Peter Gøtzsche and psychiatrist David Healy obtained regulatory documents (protocols and clinical study reports) from UK’s drug regulator (MHRA) of the two fluoxetine trials that underpinned the drug’s approval in 2002.
The discrepancies
Multiple problems were identified when Gøtzsche and Healy compared the clinical study reports of the two fluoxetine trials, with what was published in the medical journals.
Many suicidal events in people taking fluoxetine were either missing or labelled incorrectly in the published reports.
For example, in Study 1, the clinical study report described two patients who’d attempted suicide after 12 and 15 days of taking fluoxetine, but these events were excluded from the journal article.
They found problems with ‘blinding’ in both trials, meaning the trial investigators were likely aware of which patients were on the drug or the placebo.
They also found that people who were recruited into the trial, and who were already taking an antidepressant, were only given one week to “wash out” the drug from their system before commencing the randomisation process.
This caused severe withdrawal symptoms in some participants who ended up in the placebo group, making it difficult to ascertain the true level of harms in the treatment group.
Finally, when Gøtzsche and Healy looked back and analysed the data from the primary outcome – which was depression – there was no meaningful benefit from fluoxetine compared to placebo.
Journals turn a blind eye?
I wrote to both journals asking if the editors would consider correcting the discrepancies and clearly delineate the adverse events that were not reported in the published articles through an erratum.
Neither journal has done so.
The editor at Arch Gen Psychiatry (now called JAMA Psychiatry) rejected concerns about two suicide attempts that were omitted from its publication of Study 1, and has not made any corrections or clarifications.
In response, Gøtzsche said, “It’s totally unacceptable. When attempted suicides are left out of journal articles, which has happened in many such trials, it changes the safety profile of the drugs completely. This is important information that patients should know about before considering taking the pills.”
Gøtzsche drew similarities to another placebo-controlled trial in adolescents which used the drug Paxil (paroxetine).
GlaxoSmithKline’s Study 329 famously claimed that “Paroxetine is generally well tolerated and effective,” but when researchers restored the trial data using regulatory documents, the opposite became true.
“A restoration of the data from Study 329 showed that paroxetine was neither safe nor effective for treating depression in children and adolescents,” said Gøtzsche.
“Many suicidal events on paroxetine had been omitted or given an obscure name such as emotional lability. I consider this fraud,” he added.
The editor at J Am Acad Child Adolesc Psychiatry (JAACAP), which published Study 2 of fluoxetine said they would not respond to criticisms until the discrepancies documented by Gøtzsche and Healy were published in a peer-reviewed journal.
The process took over a year, but Gøtzsche and Healy’s paper has now been published in a peer-reviewed journal and sent to the JAACAP for review.
The JAACAP said in a statement:
JAACAP takes seriously its responsibility to ensure scientific integrity. As stated in the guide for authors, review of post-publication critiques will be managed according to Committee on Publication Ethics (COPE) guidelines. We will let you know the outcome of the review process…
Why does it matter?
The restoration of old trials has revealed to patients and physicians that much of the data in peer-reviewed journals are incomplete, biased, and often cherry-picked.
The exclusion of suicide attempts and suicides distorts the medical literature and prescribing guidelines to such an extent that they cannot be trusted. It also may reduce options for safer, more effective interventions such as psychotherapy.
“I’ve heard from many families whose children committed suicide because of antidepressants. We should not be prescribing them to young people,” said Gøtzsche.
“Our meta-analysis of ten trials showed that psychotherapy halved the occurrence of new suicide attempts in patients admitted after a suicide attempt. Psychotherapy is what they should be getting, not pills,” he added.
Ultimately, it’s the patients who pay the price, sometimes with their lives, from distorted clinical data, and from journals that refuse to correct glaring errors.
Antidepressants like fluoxetine double the risk of suicide and aggression in children and adolescents, they often lead to decreased quality of life, they cause sexual dysfunction in about 50% of users, and these harms may continue long after they try to quit.
In conclusion, there seems to be no rationale for using fluoxetine in young people for treating depression – the new analysis concludes the drug is unsafe and ineffective.
Disclosure: I received funding from the RIAT Support Center for publishing two Expression of Concerns in 2021.
Share this:
Related
May 9, 2023 - Posted by aletho | Deception, Science and Pseudo-Science, Timeless or most popular
No comments yet.
Featured Video
Armando Mema: Finland Used as New Frontline Against Russia
or go to
Aletho News Archives – Video-Images
From the Archives
MI5 plotted assassination of Irish PM in 1985 – Ulster Volunteer Force

RT | December 29, 2017
Former Irish Prime Minister Charles Haughey was warned by loyalist paramilitaries that they were once tasked with murdering him in an assassination plot purportedly dreamt up by the British secret service.
The sensational disclosure was sent in a letter to the Irish government, newly released under the Public Records Act, which requires documents of historical value to be published by the National Archives within 30 years.
Written on Ulster Volunteer Force (UVF) signature paper, the warning claims the terrorist organization was asked by an MI5 operative about the prospect of carrying out an attack on Republic of Ireland leader Haughey in 1985.
At the time, Haughey would have been in opposition as head of political party Fianna Fáil, but details of the solicitation did not become known to Irish authorities until 1987.
“In 1985 we were approached by a M15 officer attached to the Northern Ireland Office and based in Lisburn, Alex Jones was his supposed name,” the letter reads, according to the Irish Times. “He asked us to execute you.”… continue
Blog Roll
-
Join 2,369 other subscribers
Visits Since December 2009
- 7,817,961 hits
Looking for something?
Archives
Calendar
Categories
Aletho News Civil Liberties Corruption Deception Economics Environmentalism Ethnic Cleansing, Racism, Zionism Fake News False Flag Terrorism Full Spectrum Dominance Illegal Occupation Mainstream Media, Warmongering Malthusian Ideology, Phony Scarcity Militarism Progressive Hypocrite Russophobia Science and Pseudo-Science Solidarity and Activism Subjugation - Torture Supremacism, Social Darwinism Timeless or most popular Video War Crimes Wars for IsraelTags
Afghanistan Africa AIPAC al-Qaeda Australia BBC Benjamin Netanyahu Brazil Canada CDC Central Intelligence Agency China CIA CNN Covid-19 COVID-19 Vaccine Donald Trump Egypt European Union Facebook FBI FDA France Gaza Germany Google Hamas Hebron Hezbollah Hillary Clinton Human rights Hungary India Iran Iraq ISIS Israel Israeli settlement Japan Jerusalem Joe Biden Korea Latin America Lebanon Libya Middle East National Security Agency NATO New York Times North Korea NSA Obama Pakistan Palestine Poland Qatar Russia Sanctions against Iran Saudi Arabia Syria The Guardian Turkiye Twitter UAE UK Ukraine United Nations United States USA Venezuela Washington Post West Bank WHO Yemen Zionism
Aletho News- Armando Mema: Finland Used as New Frontline Against Russia
- Gestapo 2.0? Germany grants spy agencies sweeping new powers
- Franco-Palestinian group seeks court ban on Israeli real estate fair in Paris
- How British foreign policy is frozen in the ruins of empire
- EU risks investor exodus over Russian assets – Euroclear chief
- Moscow warns NATO over troop buildup
- EU leaders prolonging Ukraine conflict to stay in power – Swiss journalist
- Moscow car bombing injures former aide to Ukraine’s ex-PM Azarov
- Yemeni forces make major advances, complete Aden encirclement
- Trita Parsi: Trump’s Swiss Cheese Iran Plan & U.S. Break with Israel?
If Americans Knew- Israel Kills over 12, Injures Many Across Gaza
- ‘Every drawer was opened’: Palestinians report looting amid Israel’s Hebron siege
- Scoop: Israeli spy chief in D.C. as Netanyahu presses Trump to resume war
- Israel Issued More than 24,000 ‘Administrative Detention’ Orders in Three Years
- Israel Critic Van Hollen to Challenge Schumer for U.S. Senate Majority Leader
- Most violent olive harvest on record in the West Bank
- Too Awful For Even Bari’s Backers
- Disgraced neocons Feith & Libby: stop whining about ‘endless war’
- The 100-year-old Zionist plan to steal southern Lebanon
- Jeffries Refuses to Say If He Opposes US-Israeli Military Integration Measure
No Tricks Zone- New Study: Barents Sea Temperatures Were Warmer And Sea Ice Less Extensive In The 1700s Than Today
- German Authorities Start Initiative To Evaluate Public Register For Climate “Disinformation” Spreaders!
- Zonal Asymmetry of Temperature Change in the Antarctic Circumpolar Current
- New Study: The Net Fossil Fuel Contribution To Rising Atmospheric CO2 Has Been Zero For 500 Years
- Germany’s Green Energy Transition Becoming Increasingly Expensive…Another 6 Trillion Euros!
- Sudden Stratospheric Warming, Powerful El Niño Combination May Lead To Extreme Europe Cold, Energy Crisis!
- Two New Studies Find Thwaites Glacier Melt Cannot Be Driven By Human Activity Or A Warming Ocean
- E-Cars Reduce CO2 Emissions By Only 41% Compared To Internal Combustion Engine Vehicles
- Predictions Made By Renowned Climate Professor Over Past Decades Have Been Proven To Be Poor
- New Study Suggests Large Regions Of The Pacific Ocean Have Been Cooling For The Last 80 Years
Contact:
atheonews (at) gmail.com
Disclaimer
This site is provided as a research and reference tool. Although we make every reasonable effort to ensure that the information and data provided at this site are useful, accurate, and current, we cannot guarantee that the information and data provided here will be error-free. By using this site, you assume all responsibility for and risk arising from your use of and reliance upon the contents of this site.
This site and the information available through it do not, and are not intended to constitute legal advice. Should you require legal advice, you should consult your own attorney.
Nothing within this site or linked to by this site constitutes investment advice or medical advice.
Materials accessible from or added to this site by third parties, such as comments posted, are strictly the responsibility of the third party who added such materials or made them accessible and we neither endorse nor undertake to control, monitor, edit or assume responsibility for any such third-party material.
The posting of stories, commentaries, reports, documents and links (embedded or otherwise) on this site does not in any way, shape or form, implied or otherwise, necessarily express or suggest endorsement or support of any of such posted material or parts therein.
The word “alleged” is deemed to occur before the word “fraud.” Since the rule of law still applies. To peasants, at least.
Fair Use
This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more info go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.
DMCA Contact
This is information for anyone that wishes to challenge our “fair use” of copyrighted material.
If you are a legal copyright holder or a designated agent for such and you believe that content residing on or accessible through our website infringes a copyright and falls outside the boundaries of “Fair Use”, please send a notice of infringement by contacting atheonews@gmail.com.
We will respond and take necessary action immediately.
If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question.
All 3rd party material posted on this website is copyright the respective owners / authors. Aletho News makes no claim of copyright on such material.

Leave a Reply